- Sustainability
- DE&I
- Pandemic
- Finance
- Legal
- Technology
- Regulatory
- Global
- Pricing
- Strategy
- R&D/Clinical Trials
- Opinion
- Executive Roundtable
- Sales & Marketing
- Executive Profiles
- Leadership
- Market Access
- Patient Engagement
- Supply Chain
- Industry Trends
Confronting a Challenging Macroeconomic Environment with Innovation
Webinar Date/Time: Thu, Mar 16, 2023 11:00 AM EDT
Pharmaceutical and life sciences companies face a daunting challenge in the coming years, with high inflation, talent shortages, capital costs, foreign exchange impacts, and tightening regulations to contend with. Where should they focus to lower costs and maintain quality, all while encouraging innovation to transform their businesses?
Register Free:
https://www.pharmexec.com/pe_w/macroeconomic
Event Overview:
As we near the midpoint of 2023, pharmaceutical and life sciences companies are facing numerous challenges. Inflation, talent shortages, rising capital costs, foreign exchange impacts, and heavy regulatory oversight are just some of the obstacles that must be overcome. To stay afloat, organizations must find ways to reduce costs, maintain quality, and foster innovation. The question then becomes, how can this be achieved?
Key Takeaways:
- How to manage costs
- How to harness the full power of digital and cloud capabilities
- How to outperform competition with the best talent and cultivate the risk professional of the future
Key Learning Objectives:
How to manage costs without sacrificing quality or compliance
Where to apply the full power of digital and cloud capabilities
What to consider when cultivating the risk professional of the future
Speakers:
Timothy Canonico
Partner, Pharmaceutical and Life
Sciences Cyber Risk and Regulatory
Leader
PwC
Tim leads PwC's Pharmaceutical and Life Sciences Digital Regulatory Solutions Practice, focused on empowering our clients to take control of their compliance management activities by using technology and automation to better industry practices, provide key insights for operational excellence, lower the cost of compliance, and operate with agility. Speaker’s LinkedIn: https://www.linkedin.com/in/tim-canonico-795030161/
Katherine Buckley
Partner, Pharmaceutical and Life
Sciences Advisory Practice at PwC
PwC
Katherine is a pharmaceutical and life sciences industry consultant with 20 years of experience providing regulatory compliance, commercial contracting and operations, risk management and dispute resolution services to the industry. Her experience includes compliance program design, risk identification, policy and procedure development, policy adherence assessments, compliance training, the design of future state contracting, GP reporting, and healthcare professional interaction compliance programs. Speaker’s LinkedIn: https://www.linkedin.com/in/katherine-buckley-8640617/
Register Free:
ROI and Rare Disease: Retooling the ‘Gene’ Value Machine
November 14th 2024Framework proposes three strategies designed to address the unique challenges of personalized and genetic therapies for rare diseases—and increase the probability of economic success for a new wave of potential curative treatments for these conditions.
Cell and Gene Therapy Check-in 2024
January 18th 2024Fran Gregory, VP of Emerging Therapies, Cardinal Health discusses her career, how both CAR-T therapies and personalization have been gaining momentum and what kind of progress we expect to see from them, some of the biggest hurdles facing their section of the industry, the importance of patient advocacy and so much more.
